Timo Siepmann: Does Stroke Origin Change How IV Thrombolysis Helps During Thrombectomy?
Timo Siepmann, Academic Director of Dresden International University (DIU), Consultant at Carl Gustav Carus University Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Does stroke origin change how IV thrombolysis helps during thrombectomy?
Our study, spearheaded by Dr. Annahita Sedghi, shows a divergence:
- Non-cardioembolic stroke: IVT was associated with 40% faster reperfusion and 36% fewer aspiration attempts.
- Cardioembolic stroke: If distal clot migration occurred, IVT was associated with a 43% lower likelihood of successful reperfusion during thrombectomy.
In conclusion, IVT facilitates clot removal in non-cardioembolic cases but may complicate things when cardioembolic clots migrate.”
Title: IV Thrombolysis Facilitates Interventional Reperfusion in Non-Cardioembolic but Not Cardioembolic Stroke
Authors: Annahita Sedghi, Daniel P. O. Kaiser, Martin Arndt, Norma J. Diel, Erik Simon, Witold H. Polanski, Volker Puetz, Hagen B. Huttner, Timo Siepmann
Read the Full Article on Annals of Clinical and Translational Neurology

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia